While the risk of infusion site infection still exists with sc administration, infusion site infections are generally limited to cellulitis and very rarely progress to. Procedure for the use of mckinley t34 syringe driver to. Guidelines for subcutaneous infusion device management in. April 2017 introduction palliative care patients often exhibit multiple symptoms that require the use of numerous drugs. Battery operated and portable refilled every 24 hours holds 1050ml syringesup to 30ml with lockbox pump identifies type of syringe and size. Saftintima catheters are used to reduce local site reactions and therefore increase longevity and reduce needle. Choose syringe and needle technology that makes a difference. If the patient is in pain, vomiting or very agitated, give a stat sc injection of appropriate medication while setting up the syringe driver. A single drug, or more often a combination of drugs is given via a slow subcutaneous infusion to help control symptoms when other routes of administration are no longer viable, feasible or preferred. You might have been given a syringe driver, to help control pain, sickness, agitation or fits. Syringe driver drug compatibilities guide to palliative care practice 2016 sodium chloride 0. Syringe driver drug compatibilities guide to palliative care. Guidelines for syringe driver management in palliative care.
Syringe pumps will be set up by a specialist nurse, district nurse or gp. When and how to use a syringe driver in palliative. A syringe driver is a small battery operated pump designed to deliver medication sub cutaneously just under the skin over a 24 hour period. For these injections, you must consider the amount of body fat the needle has to go through. Syringe drivers continuous subcutaneous infusion marie curie. Using syringe drivers in palliative care within a rural, community setting. The syringe driver is a simple and costeffective method of delivering a continuous subcutaneous infusion csci. For these injections, you must consider the amount of body fat the needle has to go. Mckinley t34 syringe driver studied widely and found to be the most safe and reliable of all syringe pumps. Incidence and causes for syringe driver site reactions. An initial subcutaneous injection may also be required as a loading dose to. With a subcutaneous injection, a needle is inserted just under the skin at. Cumbria syringe driver training attaching to patient. Syringe driver definition of syringe driver by medical.
A single drug, or more often a combination of drugs is given via a slow subcutaneous infusion to help control symptoms when other routes of administration are no. The syringe driver pump is able to deliver a combination of medications and does so. Procedure for the use of mckinley t34 syringe driver to deliver a continuous subcutaneous infusion in palliative care for adults page 8 of 41 9. It is most frequently used in palliative care particularly cancer care, bypassing problems such as. A csci provides a safe and effective way of drug administration and can be used to maintain symptom control in patients who are no longer able to take oral medication. For administration by continuous subcutaneous infusion drug dose duration diluent. The multifurcated steel needle infusion sets are designed for subcutaneous infusion of immunoglobulins igg for the treatment of primary immune deficiency. Subcutaneous injection is an injection into the fat layer between the skin and the underlying muscle. Currently, insuflon is being used successfully in many specialties throughout the hospital and at home to administer. Continuous subcutaneous infusion csci syringe driver mckinley t34 lock on pump aims of syringe driver use promote stable plasma concentration of medication used for maximum symptom control eliminate the need for repeated injections, suppositories or oral medication. When the oral route is no longer appropriate, a syringe driver can be used to ensure continued symptom control. When subcutaneous infusion is preferred, neria infusion sets are the perfect option.
Before mixing any drugs together in a subcutaneous infusion, check. Purpose the purpose of the guideline is to ensure a standardised approach when using a syringe driver to administer medications subcutaneously and therefore optimise patient symptom. Bd saftintima has a telescoping needle shield which completely covers the needle as it is withdrawn, reducing the risk of needle stick injuries the integrated system approach reduces the risk of infection for the patient as the subcutaneous route does not interact with the main blood vessels. Pdf the benefits and drawbacks of syringe drivers in. A syringe driver is a small, portable, powerdriven device used to administer a continuous 24hour dose of medication. The patient inserts an infusion set under the skin and connects it to the infusion pump. This video will describe how to use the saftintima 24 gauge subcutaneous needle by bd canada. In summary, the authors conclude from the literature and the evidence gained in this study that, in cases without complications, leaving a needle in situ for a maximum of seven days seems to be a safe practice.
Shading indicates areas that must be kept sterile before and during parenteral injections. A bd saftintima is a needleless closed indwelling subcutaneous catheter system, which is used for subcutaneous administration of medications, either as a continuous infusion or for breakthroughbolus doses. Subcutaneous sc drug infusion by portable syringe driver has had a significant impact on pain management. A subcutaneous injection is a method of administering medication. Syringe drivers are small portable usually battery operated devices used in palliative care. Syringe pumps for palliative care are programmed to deliver the medicines over a 24hour period, so a new syringe of medicines is usually set up once per day. As a continuous infusion using a syringe driver infusion pump with a prefilled syring. Since then, many more products have been approved by the ema or the fda for subcutaneous selfadministration, typically using an infusion pump or syringe driver pump. Introduction this protocol covers all inpatient and community services within harrogate and district nhs foundation trust hdft. A syringe driver is useful when the oral route of administration is not possible and repeated subcutaneous doses are inappropriate, ineffective or impractical. Subcutaneous morphine infusion by syringe driver for terminally iii patients h.
Only use drugs that are known to be effective via the sc route. Feb 03, 2020 the syringe has markings from 10 to 100. Its sometimes called a continuous subcutaneous infusion. The syringe driver is used to administer a continuous subcutaneous. Whilst the preferred route of medication administration in paediatric palliative care is the oral one, there may be occasions when this is impractical or undesirable. Andrew dickman, jennifer schneider, james varga 2005 2nd ed. Subcutaneous administration of drugs in palliative care. Continuous subcutaneous administration of medicines using a syringe driver often. Safe practice in syringe pump management nursing times. Continuous subcutaneous administration of medicines using a syringe driver often becomes necessary for the control of symptoms during palliative care. Asepto syringe a syringe designed to fit directly into large lumen tubing. Syringe driver dose guidance for opioid naive patient for use in community and care homes please allow dose adjustment to maximise symptom control one, or all of these may be needed and should be available for optimum end of life care. How to give an im intramuscular injection ventrogluteal buttock muscle duration.
Discuss the use of the subcutaneous syringe driver at end of life in the hospital setting promote excellence discuss culture change and challenges in implementation of evidence based practice spread the word. Instructions for subcutaneous injections medview systems. It has a needle that is slightly longer than an insulin syringe. If the combination is not listed in this guideline or its companion document consult. There have been several developments in this field since the second edition of this highly successful. The syringe driver continuous subcutaneous infusions in palliative care 3rd ed. Intramuscular injections go directly into a muscle. Subcutaneous infusion systems can be designed with smaller needle sizes, which may decrease pain during infusion. In the last days of life when the patients have difficulty tolerating oral medication, continuous subcutaneous infusion is a superior alternative to frequent intermittent parenteral injections.
The syringe driver, continuous subcutaneous infusions in palliative care. Syringe driver drug compatibilities guide to palliative. Subcutaneous catheter devices management of insuflon and bd. The pump holds a syringe containing medication and this is connected to the patient via a small needle and a line. Advantages of subcutaneous drug delivery enable injections. This catheter system requires a needle and syringe to administer the medication through the device. Ondrugdelivery magazine, issue 101 oct 2019, pp 2832 aurelie pager describes how reducing needle length can improve the risk profile of subcutaneous injections and can make injecting viscous formulations easier and quicker, and highlights bds development programme for an innovative shorter needle with.
Results for subcutaneous syringe driver 1 10 of 117 sorted by relevance date click export csv or ris to download the entire page or use the checkboxes to select a subset of records to download. The needle, or soft plastic cannula, is usually placed in the upper arm, leg or abdomen. Continuous subcutaneous administration of medicines via. Hizentra, vivaglobin, and hyqvia are only available for subcutaneous delivery, but other pi products can be purchased for intravenous or intramuscular use.
Subcutaneous morphine infusion by syringe driver for. Administration of drugs by infusion pumps in palliative. Dec 02, 2016 a syringe driver takes 34 hours to establish a steady state drug level in plasma. Subcutaneous injection sites, how to give subcutaneous. Management of subcutaneous infusions in palliative care. Although medicines can also be administered by other routes, such as rectal or sublingual, a further advantage of a continuous subcutaneous infusion is that any peaks and troughs of. The subcutaneous administration of medications using a syringe driver is a common and. The use of continuous subcutaneous infusion via a syringe driver gives good symptom control.
Mckinley t34 syringe driver guidelines for adult supportive. It allows the continuous delivery of a range of therapies to aid patient comfort. Continuous subcutaneous administration of medicines via the t34 syringe driver for adult palliative care patients. Mukoreka j, sisay i 2015 safe practice in syringe pump. Monitoring the continuous subcutaneous infusion via syringe driver every 4 hours as a minimum. Continuous subcutaneous administration of medicines via the. When and how to use a syringe driver in palliative care. Clinical protocol for the use of syringe drivers in palliative care patients. Drugs for subcutaneous administration in syringe drivers. Subcutaneous drug infusion compatibility guidelines. This article will outline the use of continuous subcutaneous infusion pumps, known as syringe drivers, including their benefits and drawbacks in a palliative care context. Pager a, 8 mm needle improving subcutaneous chronic drug delivery. Ondrugdelivery magazine, issue 101 oct 2019, pp 2832 aurelie pager describes how reducing needle length can improve the risk profile of subcutaneous injections and can make injecting viscous formulations easier and quicker, and highlights bds development programme for an. Resite subcutaneous cannula as per seslhdpr19 subcutaneous needle insertion and management procedure discard all equipment including extension tubing and redraw new medications prepare a new syringe and extension line restart the syringe driver as per appendix 1 contact the medical officer.
Graham and others published syringe drivers and subcutaneous sites. The cme t34 ambulatory syringe driver is a portable, battery operated device for delivering medication by continuous subcutaneous infusion csci, which. Results for subcutaneous syringe driver 1 10 of 118 sorted by relevance date click export csv or ris to download the entire page or use the checkboxes to select a subset of records to download. Diazepam, chlorpromazine and prochlorperazine are too. Runs mls per hour but can be set and locked to run over 24 hours only. If compatibility is an issue, the use of two syringe driver devices3 or regular or prn subcutaneous injection should be considered. Choosing a syringe and needle size for an injection. Muscle is deeper than the subcutaneous layer of skin, so the needle used for intramuscular injections must be thicker and longer.
The tube is inserted using a very thin needle, which is then removed. The syringe driver must be stored with the barrel clamp arm in the closed position inside the lockable box. The use of a subcutaneous or intravenous infusion using a syringe driver to deliver medications has certain advantages. A needleless closed indwelling subcutaneous catheter system, which is used for subcutaneous administration of medications, either as a continuous infusion or for breakthroughbolus doses. The syringe driver used across asph is the mckinley t34 ambulatory syringe pump. Subcutaneous syringe driver niki t43 with documented prescription by rmo niki t34 syringe pump, rigid locked box and carry pouch saftintima catheter. Jan 10, 2018 a syringe driver is a small battery operated pump designed to deliver medication sub cutaneously just under the skin over a 24 hour period.
1289 855 1123 1298 1632 1487 1330 233 1027 1152 1000 968 1475 1006 1537 129 1218 1198 167 169 1007 1049 1078 1100 1532 485 112 1086 476 239 1358 726 839 901 896 737 1087 216 375 237